Vivance
Natural health product licensed in Canada
- Licence holder
- Fabrication JAMP Pharma Inc. / JAMP Manufacturing Inc.
- NPN or DIN-HM
- 80027299
- Status
- Inactive licence
- Licence date
- 13 September 2011
- Revision date
- 9 May 2018
- Form
- Liquide oral
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Echinacea purpurea Source : Racine Extraction ratio : 4:1 Dry plant equivalent : 400 mg | 100 mg | Not calculated |
| Spirulina maxima Source : Cellule entière Extraction ratio : 4:1 Dry plant equivalent : 1,200 mg | 300 mg | Not calculated |
Non-medicinal ingredients
Mélasse, 4-hydroxybenzoate de méthyle, Saveur naturelle de framboise, Alcool éthylique, (p)-hydroxybenzoate de propyle, Glycérine, Benzoate de sodium, Fructose, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 ampoule | 1 day |
Uses authorised in Canada
Vivance est utilise en pytothérapie comme tonique en cas d'affaiblissement généralisé et/ou pour aider durant la convalesence. Utilisé en pytothérapie pour aider à amélorer le rendement mental et/ou physique suite à des périodes d'effots mentaux et/ou physiques. Utilisé en pytothérapie pour aider à accroître les capacités physiques/la performance physique (dans les cas de stress physique).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Certaines personnes pourraient souffrir d'insomnie, d'anxiété, ou de maux de tête. Si tel est le cas, cesser l'utilisation. Une hypersensibilité, comme une allergie, peut se manifester. Si tel est le cas, cesser l'utilisation. Ne pas utiliser si la bande sécuritaire est brisée. Pour usage thérapeutique seulement. Conserver ce produit de même que tout médicament hors de la portée des enfants.
Source
Official Health Canada record, licence 80027299
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging